Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.



From the category archives: OBN News

Company announcement

Oxford Immunotec Global PLC Announces Agreement to Sell 2,500,000 Ordinary Shares

Oxford Immunotec intends to use the net proceeds from the offering for working capital and general corporate purposes.

Read the rest of entry »

China- Visit by the Future Health Industry Entrepreneurs Association

The Department for International Trade Life Sciences Organisation (DIT LSO) and the China Britain Business Council (CBBC) will be hosting a delegation from the Future Health Industry Entrepreneurs Association (FHA) from China on the morning of Tue 5 Sep.

Read the rest of entry »

ELISA-like Assay for Hyaluronic Acid

AMSBIO announces the launch of a new Hyaluronic Acid Quantification Kit, based on a highly specific and tightly binding protein to detect and measure Hyaluronic Acid, also known as Hyaluronan or HA.

 

Read the rest of entry »

Oxford BioMedica signs major supply deal with Novartis

Oxford BioMedica has sealed a major deal with Novartis to supply the Swiss drug giant with lentiviral vectors used to create cell therapy products, including CTL019 and other undisclosed Chimeric Antigen Receptor T cell (CART) products.

Read the rest of entry »

Isansys’ ‘washable’ high-tech patient sensors feature in the Government’s latest Great Britain campaign

Isansys Lifecare is delighted to announce that we have been chosen to feature in the Government's “GREAT for Imagination” campaign.

Read the rest of entry »

Immunocore and MEPC announce significant laboratory expansion at Milton Park in Oxfordshire, UK

Additional space will provide purpose-built research laboratories accommodating around 450 scientists at Immunocore

Read the rest of entry »

Precision for Medicine Expands Its Global Footprint for Oncology Development Services

Leadership in place; Clinical Operations teams growing throughout Europe

BETHESDA, Md., July 6, 2017 /PRNewswire/ -- Precision for Medicine today reported important progress in its global expansion plan. Precision for Medicine, with its oncology research team Precision Oncology, is rapidly expanding its global footprint to better serve clients developing oncology treatments. Investment in executive leadership and operational teams are underway across Europe, providing integrated, full-service clinical trial execution services throughout the continent.

Read the rest of entry »

Wickham Laboratories Now Offering Full Suite of Medical Device Biocompatibility and Safety Testing

Medical device testing is one of the most complex services offered in the life sciences sector, both for the diversity of the product tested and for the different level of safety or biocompatibility required prior to approval for use in patients.

Read the rest of entry »

Immunocore announces third oncology target selected in discovery collaboration with GlaxoSmithKline

Immunocore will generate a novel ImmTAC® molecule against the selected target which is relevant in multiple cancers.

Read the rest of entry »

AMSBIO announces the launch of DermaChip®

A new high throughput assay technology that allows scientists, for the first time, to reliably measure the genotoxic risk of a whole range of environmental agents (including cleaning agents, household products and industrial chemicals as well as cosmetics) to our skin.

Read the rest of entry »

Pages: Previous1234567...9NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.